Autres langues Seoulin Bioscience Co.,Ltd.

Actions

A038070

KR7038070009

Cours en clôture Korea S.E. Autres places de cotation 00:00:00 28/06/2024			Varia. 5j.	Varia. 1 janv.
8 370 ^KRW	+0,48 %		-2,33 %	-9,02 %

14/05	Seoulin Bioscience Co. annonce ses résultats pour le premier trimestre clos le 31 mars 2024	CI
20/03	Seoulin Bioscience Co. annonce ses résultats pour l'exercice clos le 31 décembre 2023	CI

Autres langues

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

Seoulin Bioscience Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	14/05
Seoulin Bioscience Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	20/03
Seoulin Bioscience Co.,Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	13/11
Seoulin Bioscience Co.,Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	11/08/23
Seoulin Bioscience Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	15/05/23
Seoulin Bioscience Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	15/03/23
Seoulin Bioscience Co.,Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	14/11/22
Seoulin Bioscience Co.,Ltd.(KOSDAQ:A038070) dropped from S&P Global BMI Index	19/09/22
Light Farm Tech Co., Ltd. announced that it has received KRW 1.999995 billion in funding from Seoulin Bioscience Co.,Ltd.	08/08/22
Light Farm Tech Co., Ltd. announced that it expects to receive KRW 1.999995 billion in funding from Seoulin Bioscience Co.,Ltd. and other investors	22/07/22
Seoulin Bioscience Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	16/05/22
Seoulin Bioscience Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	10/03/22
Seoulin Bioscience Co.,Ltd. announced that it has received KRW 30 billion in funding from Shinhan Investment Corp., Investment Arm, Hanyang Securities Co., Ltd., Investment Arm, Mirae Asset Daewoo Co., Ltd., Investment Arm, Mirae Asset Capital Co,Ltd., Investment Arm, Cornerstone Investment Partners Co., Ltd., and other investors	24/11/21
Seoulin Bioscience Co.,Ltd. announced that it expects to receive KRW 30 billion in funding from Shinhan Investment Corp., Investment Arm, Hanyang Securities Co., Ltd., Investment Arm, Mirae Asset Daewoo Co., Ltd., Investment Arm, Mirae Asset Capital Co,Ltd., Investment Arm, Cornerstone Investment Partners Co., Ltd., and other investors	22/11/21
Seoulin Bioscience Co.,Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	15/11/21
Seoulin Bioscience Co.,Ltd.(KOSDAQ:A038070) added to S&P Global BMI Index	20/09/21
Seoulin Bioscience Co.,Ltd.'s Equity Buyback announced on June 11, 2019, has expired.	12/06/20
Tranche Update on Seoulin Bioscience Co.,Ltd.'s Equity Buyback Plan announced on August 8, 2019.	10/02/20
Seoulin Bioscience Co.,Ltd.'s Equity Buyback announced on August 8, 2019, has expired with 92,246 shares, representing 1.2% for KRW 802.37 million.	08/02/20
Seoulin Bioscience Co.,Ltd. announces an Equity Buyback for KRW 1,000 million worth of its shares.	08/08/19

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Seoulin Bioscience Co.,Ltd.

Actions

A038070

KR7038070009

Autres langues

Filtres